Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trialAnthony Traboulsee, Brian G. Weinshenker, Edward Fox et al.|The Lancet Neurology|2020Cited by 495
Clinical, Neuroimaging, and Genetic Markers Associated with Cognitive and Functional Outcomes After Traumatic Brain InjuryKhrystyna Duve, Oleksandr Kamyshnyi, Svitlana Shkrobot et al.|Journal of Clinical Medicine|2025Cited by 0